Q1 EPS Estimates for Legend Biotech Raised by HC Wainwright

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN – Free Report) – Analysts at HC Wainwright raised their Q1 2026 earnings per share estimates for Legend Biotech in a research report issued on Thursday, July 17th. HC Wainwright analyst M. Kapoor now expects that the company will earn $0.14 per share for the quarter, up from their […]

Leave a Reply

Your email address will not be published.

Previous post Scotiabank Raises Earnings Estimates for Freeport-McMoRan
Next post Brokerages Set Canadian National Railway Company (NYSE:CNI) Price Target at $120.86